Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing
Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Purpose Evaluate dalcetrapib's potential to prolong QT intervals in healthy subjects. Methods This was a single-center, randomized, active and placebo-controlled, six-sequence, three-period cross-over study. Participants [18-65 years; body mass index (BMI) 18-30 kg/m²] were randomized to daily doses of dalcetrapib 600 mg (therapeutic) or 3,900 mg (...
Alternative Titles
Full title
Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_633058998
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_633058998
Other Identifiers
ISSN
0031-6970
E-ISSN
1432-1041
DOI
10.1007/s00228-010-0841-2
